EXPLORER -HCM Cardiac Imaging Data Presented at AHA 2020 Scientific Session with Simultaneous Publication in Circulation
ECHO Data from EXPLORER-HCM Show Mavacamten Treatment Improved Cardiac Structure and Mitral Valve Function in Obstructive Hypertrophic Cardiomyopathy Patients
Registry to Enable Prospective Safety Study “DISCOVER-HCM” to Track Long-Term Safety and Effectiveness of Mavacamten in Patients with Symptomatic, Obstructive Hypertrophic Cardiomyopathy
Acquisition of MyoKardia by Bristol-Myers Squibb Expected to Close During 4th Quarter of 2020
Bristol Myers Squibb (NYSE:BMY) today reports results for the third quarter of 2020, which reflect strong product sales, continued pipeline advancement and robust operating performance.
BRISBANE, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced three awardees of the 2020 MyoSeeds™ Research Grant Program, who have been selected to receive $250,000...
Bristol Myers Squibb (NYSE: BMY) and MyoKardia, Inc. (Nasdaq: MYOK) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, in connection...
EXPLORER Cardiac MRI Substudy Selected as Featured Scientific Presentation
NEW YORK, NY / ACCESSWIRE / October 29, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: CIT Group Inc. (NYSE:CIT) concerning potential violations of the federal...
NEW YORK, NY / ACCESSWIRE / October 24, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Standard AVB Financial Corp. (NASDAQ:STND) concerning potential violations of the federal...